Transient elastrography (TE)-based liver stiffness may be used as an alternative to fibrosis progression rates (FPRs) to estimate chronic hepatitis C (CHC) prognosis, a recent study found. The meta-analysis estimated prognosis in treatment-naïve CHC patients using TE-based liver stiffness progression rates (LSPR) as an alternative to FPRs and to compare consistency between LSPRs and FPRs. Among the details:
- 27 studies reporting on 39 groups of patients (n=5,874) were identified with 35 groups allowing for indirect and 8 for direct estimation of LSPR.
- ~58% of patients were HIV/HCV coinfected.
- The estimated time-to-cirrhosis based on TE vs biopsy was 39 and 38 years, respectively.
- Non-invasive prognosis of HCV is consistent with FPRs in predicting time-to-cirrhosis.
Erman A, Sathya A, Nam A, et al. Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: A systematic review and meta-analysis. [Published online ahead of print January 24, 2018]. J Viral Hepat. doi:10.1111/jvh.12846.
This Week's Must Reads
Relevance of Health Literacy to CV Health, Circulation; ePub 2018 Jun 4; Magnani, et al
Diabetes & Long-Term Kidney Disease, Diabetes Care; ePub 2018 Jun 1; Warren, et al
Maternal Loss of Control Over Eating, Am J Clin Nutr; ePub 2018 Jun 5; Micali, et al
Efficacy of Brief Behavioral Treatment for Insomnia, Sleep Medicine; ePub 2018 Jun 2; McCrae, et al
Opioid-Related Adverse Events in Surgical Patients, JAMA Surg; ePub 2018 May 23; Shafi, et al
Must Reads in Hepatitis
Glecaprevir/pibrentasvir Can Reduce HCV Tx Duration, Hepatol Int; ePub 2018 May 29; Abutaleb, et al
Estimates of HCV by Race and Sex in US, BMC Infect Dis; ePub 2018 May 16; Hall, et al
Efficacy of DAA Therapy for HCV in Older Adults, J Am Geriatr Soc; ePub 2018 May 25; Mazzarelli, et al
HCV Treatment in People Who Inject Drugs, Open Forum Infect Dis; ePub 2018 May 23; Alimohammadi, et al
Risk of HCV Among Vulnerable Populations, J Viral Hepat; ePub 2018 May 31; Aisyah, et al